Table 2 Comparison of laboratory indicators in each group.

From: Assessment of pit viper associated subclinical myocardial injury by speckle tracking imaging

Characteristics

Healthy Controls(n = 34)

Snakebite patients(n = 37)

Z/t

p

Mild group(n = 25)

Moderate group(n = 7)

Severe group(n = 5)

H

p

LDH

(U/L)

181.35 ± 28.08

221.83 ± 64.57

6.51

0.02

188.000

(170.0,230.0)

242.000

(193.0,244.0)

245.000

(179.0,276.0)

2.489

0.288

CK

(U/L)

88.000

(76.5,104.5)

144.000

(105.0,228.0)

 − 4.473

 < 0.001

127.000

(95.0,197.0)

177.000

(143.0,239.0)

196.000

(156.0,420.5)

3.984

0.136

CK-MB

(ng/mL)

3.050

(2.7,4.1)

3.760

(2.8,5.8)

 − 1.982

0.048

3.690

(2.6,4.9)

4.140

(3.1,5.9)

9.220

(4.9,9.7)

5.893

0.053

α-HBD(U/L)

96.000

(80.3,116.5)

156.000

(135.5,181.0)

 − 4.892

 < 0.001

148.000

(131.0,185.0)

156.000

(147.0,177.0)

159.000

(123.5,169.0)

0.107

0.948

cTnI

(ng/L)

0.120

(0.0,0.3)

2.890

(2.2,4.8)

 − 7.201

 < 0.001

2.400

(1.5,3.1)*

3.320

(2.6,7.5)

8.120

(5.2,12.6)

12.632

0.002

WBC

(× 109/L)

6.185

(4.6,7.3)

9.530

(6.6,12.4)

 − 3.503

 < 0.001

8.420

(6.0,10.1)*

11.040

(6.4,15.8)

13.760

(9.8,19.2)

6.207

0.045

CRP

(mg/L)

0.500

(0.5,0.5)

0.500

(0.5,3.0)

 − 2.958

 < 0.001

0.500

(0.5,0.7)

0.500

(0.5,5.7)

2.500

(1.5,13.0)

6.500

0.039

  1. Data are expressed as the Median (P25, P75). LDH, lactate dehydrogenase; CK, creatine kinase; CK-MB, MB fraction of creatine kinase; α-HBD, alpha-hydroxybutyrate dehydrogenase; cTnI, cardiac troponin I; WBC, white blood cells; CRP, C-reactive protein. *p < 0.05, compared with the severe group.
Back to article page